|
TMEM87B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.776300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.363800E-01 |
| Normal-vs-Stage2 |
1.725220E-01 |
| Normal-vs-Stage3 |
9.035900E-02 |
| Normal-vs-Stage4 |
1.041230E-01 |
| Stage1-vs-Stage2 |
2.571000E-01 |
| Stage1-vs-Stage3 |
1.184960E-01 |
| Stage1-vs-Stage4 |
6.832000E-02 |
| Stage2-vs-Stage3 |
9.385200E-01 |
| Stage2-vs-Stage4 |
6.429400E-01 |
| Stage3-vs-Stage4 |
5.409200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.211800E-01 |
| Normal-vs-AfricanAmerican |
2.170800E-01 |
| Normal-vs-Asian |
6.107600E-02 |
| Caucasian-vs-AfricanAmerican |
6.996800E-01 |
| Caucasian-vs-Asian |
5.092100E-02 |
| AfricanAmerican-vs-Asian |
9.041900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.083400E-01 |
| Normal-vs-Female |
2.458300E-03 |
| Male-vs-Female |
3.882100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.115600E-01 |
| Normal-vs-Extreme_Weight |
8.345400E-01 |
| Normal-vs-Obese |
4.568300E-02 |
| Normal-vs-Extreme_Obese |
2.888800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.533000E-01 |
| Normal_Weight-vs-Obese |
2.671600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.286200E-01 |
| Extreme_Weight-vs-Obese |
2.302400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.019600E-01 |
| Obese-vs-Extreme_Obese |
1.255200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.640200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.453900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.366800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.598600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.666400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.434700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.924900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.330300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.269800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.600600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.802800E-01 |
| Normal-VS-Type2 PRCC |
8.470000E-01 |
| Normal-VS-KIRP CIMP |
4.46870000000432E-05 |
| Normal-VS-Unclassified PRCC |
1.198030E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.629000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
1.325420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.72957262032514E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
1.484800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.03929999999364E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.457400E-01 |
| Normal-vs-N1 |
2.063000E-03 |
| Normal-vs-N2 |
1.331820E-01 |
| N0-vs-N1 |
1.199230E-03 |
| N0-vs-N2 |
2.040600E-01 |
| N1-vs-N2 |
4.443600E-01 |
|
|
